Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01
Published December 26, 2012 · Recall initiated: November 21, 2012
Summary
FDA records drug Class II recall D-096-2013, published December 26, 2012 and initiated November 21, 2012. Recalling firm: Hospira, Inc.; Status: Terminated; Reported quantity: 145,400 vials; Lot: Lot #: 11-293-DK, Exp 05/01/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.
What to do
Voluntary: Firm initiated · Letter
Get an email if NALBUPHINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NALBUPHINE HYDROCHLORIDE
- Manufacturer
- Hospira, Inc.
- Distributor
- Nationwide and Puerto Rico.
- Lot
- Lot #: 11-293-DK, Exp 05/01/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACholetec - Kit for the Preparation of Technetium Tc 99m Mebrofenin, 10 vials per box, Nonradioactive,December 26, 2012
- FDACellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDCDecember 26, 2012
- FDACaziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025December 26, 2012
- FDAClean & Clear advantage, 3-in-1 foaming wash 8 FL. OZ. (240 mL) bottle, OTC, Distributed in the US by: JohnsonDecember 26, 2012
- FDAProcrit (epoetin alfa) injection, 20000 units/mL, 4 mL vial; Mfg By: Amgen Inc., Thousand Oaks, CA 91320;December 26, 2012
- FDALidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials perDecember 26, 2012
Questions about this recall
Was Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01 recalled?
Yes. FDA published recall D-096-2013 on December 26, 2012. Reported hazard: Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NALBUPHINE HYDROCHLORIDE.